9781573315326

The Maillard Reaction: Chemistry at the Interface of Nutrition, Aging, and Disease, Annals of the New York Academy of Sciences, Volume 1043

by ; ; ;
  • ISBN13:

    9781573315326

  • ISBN10:

    157331532X

  • Edition: 1st
  • Format: Paperback
  • Copyright: 2005-08-01
  • Publisher: Wiley-Blackwell

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

List Price: $149.95 Save up to $14.99
  • Rent Book $134.96
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-4 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

The Maillard reaction, first described during the early 20th century, originally referred to the browning reaction that occurs between amino acids and sugars during the cooking and processing of foods. This reaction contributes to the color, taste, aroma, and texture of foods, and also affects their nutritional and toxicological properties.The Maillard reaction, which has been at the crossroads of food and biomedical sciences, is now also known to contribute to the natural and normal aging of tissue proteins and other biomolecules. It is also implicated in the pathologic processes of a range of age-related chronic diseases, including arthritis, atherosclerosis, diabetes, and neurodegenerative diseases. The role of the Maillard reaction in diabetes and its complications has become a major focus of research, leading to a better understanding of the importance of oxidative stress, lipid peroxidation, and hyperlipidemia in diabetic complications.This volume addresses all of these issues - -from food to biomedical sciences -- and highlights current research trends, including the identification of new biomarkers, nutrition, and toxicology, and the role of oxidative stress, advanced glycoxidation and lipoxidation end products (AGE/ALEs) in aging and chronic disease.The last section of the book, devoted to recent research on AGE/ALE inhibitors in animal models and clinical trials, assesses the current status of pharmaceutical interventions for retarding the Maillard reaction and the pathophysiology associated with aging and age-related disease.NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.

Table of Contents

Preface.
By JOHN W. BAYNES, VINCENT M. MONNIER, JENNIFER M. AMES, AND SUZANNE R. THORPE
xix
Dedication: Dr. Paul-Andre Finot and Dr. Samuel Rahbar.
By JENNIFER M. AMES AND VINCENT M. MONNIER
xxi
Keynote Papers
Historical Perspective of the Maillard Reaction in Food Science.
By PAUL-ANDRÉ FINOT
1(8)
The Discovery of Glycated Hemoglobin: A Major Event in the Study of Non-enzymatic Chemistry in Biological Systems.
By SAMUEL RAHBAR
9(11)
Part I. Chemistry of the Mallard Reaction
Taste-Active Maillard Reaction Products: The "Tasty" World of Nonvolatile Maillard Reaction Products.
By THOMAS HOFMANN
20(10)
Current Status of Acrylamide Research in Food: Measurement, Safety Assessment, and Formation.
By IMRE BLANK
30(11)
Oxidative Pyrolysis and Postpyrolytic Derivatization Techniques for the Total Analysis of Maillard Model Systems: Investigation of Control Parameters of Maillard Reaction Pathways.
By V.A. YAYLAYAN, L. HAFFENDEN, F.L. CHU, AND A. WNOROWSKI
41(14)
Identification of N7-(1-Carboxyethyl)-Arginine, a Novel Posttranslational Protein Modification of Arginine Formed at High Hydrostatic Pressure
By NADJA ALT AND PETER SCHIEBERLE
55(4)
Labeling Studies on the Formation Pathway of NE-Carboxymethyllysine in Maillard-type Reactions.
By MARTINA KASPER AND PETER SCHIEBERLE
59(4)
Elucidation of Chemical Pathways in the Maillard Reaction by 170-NMR Spectroscopy.
By FABIEN ROBERT, FRANCIA ARCE VERA, FRANK KERVELLA, TOMAS DAVIDEK, AND IMRE BLANK
63(10)
The Effect of Reaction Conditions on the Origin and Yield of Acetic Acid Generated by the Maillard Reaction.
By TOMAS DAVIDEK, STEPHANIE DEVAUD, FABIEN ROBERT, AND IMRE BLANK
73(7)
Formation of Mutagenic/Carcinogenic Heterocyclic Amines under Moderate Conditions.
By NAOHIDE KINAE, CHISATO MORI, KAORI KUJIRAI, SHOJI MASUMORI, AND SHUICHI MASUDA
80(5)
Maillard Reactions of Ribose 5-Phosphate and Amino Acids.
By ROGER SANDWICK, MATTHEW JOHANSON, AND ELIZABETH BREUER
85(12)
Protein Cross-Linking in Food.
By J.A. GERRARD, S.J. MEADE, A.G. MILLER, P.K. BROWN, S.B.M. YASIR, K.H. SUTTON, AND M.P. NEWBERRY
97(7)
Chemistry and Biological Effects of Melanoidins and Glyceraldehyde-Derived Pyridinium as Advanced Glycation End Products. By
FUMITAKA HAYASE, TERUYUKI USUI, KAZUYUKI NISHIYAMA, SHIGEYUKI SASAKI, YOSHINOBU SHIRAHASHI, NAOYUKI TSUCHIYA, NAOKO NUMATA, AND HIROHITO WATANABE
104(7)
Part II. Reactive Carbonyls and the Maillard Reaction in Biological Systems
Dicarbonyl Intermediates in the Maillard Reaction.
By PAUL J. THORNALLEY
111(7)
Ornithine Is a Novel Amino Acid and a Marker of Arginine Damage by Oxoaldehydes in Senescent Proteins.
By DAVID R. SELL AND VINCENT M. MONNIER
118(11)
Formation of α-Animoadipic and γ-Glutamic Semialdehydes in Proteins by the Maillard Reaction.
By MITSUGU AKAGAWA, DAISUKE SASAKI, YAYOI KUROTA, AND KYOZO SUYAMA
129(6)
Methylglyoxal Can Modify GAPDH Activity and Structure.
By HYON JAE LEE, SCOTT. K. HOWELL, REBECCA J. SANFORD, AND PAUL BEISSWENGER
135(11)
Effect of Glucose Concentration on Formation of AGEs in Erythrocytes in Vitro
By RYOJI NAGAI, ELIZABETH K. DEEMER, JONATHAN W. BROCK, SUZANNE R. THORPE, AND JOHN W. BAYNES
146(5)
Methylglyoxal Induces Apoptosis through Oxidative Stress–Mediated Activation of p38 Mitogen-Activated Protein Kinase in Rat Schwann Cells.
By MICHIRU FUKUNAGA, SATOSHI MIYATA, SATOMI HIGO, YASUHIRO HAMADA, SHIGEMITSU UEYAMA, AND MASATO KASUGA
151(7)
Dicarbonyl Stress and Apoptosis of Vascular Cells: Prevention by αB-Crystallin.
By RAM H. NAGARAJ, TOMOKO OYA-ITO, MANJUNATHA BHAT, AND BINGFEN LIU
158(8)
Phototransformations of Advanced Glycation End Products in the Human Eye Lens due to Ultraviolet A Light Irradiation.
By O.K. ARGIROV, B. LIN, AND B.J. ORTWERTH
166(8)
The Maillard Reaction for Sunlight Protection.
By RAMON M. FUSARO AND EDWIN G. RICE
174(10)
K2P—a Novel Cross-Link from Human Lens Protein.
By RONGZHU CHENG, QI FENG, OGNYAN K. ARGIROV, AND BERYL J. ORTWERTH
184(11)
Assessment of Protein Function following Cross-Linking by a-Dicarbonyls
By ANTONIA G. MILLER AND JULIET A. GERRARD
195(6)
Ketosis Leads to Increased Methylglyoxal Production on the Atkins Diet.
By BENJAMIN G.K. BEISSWENGER, ELIZABETH M. DELUCIA, NANCY LAPOINT, REBECCA J. SANFORD, AND PAUL J. BEISSWENGER
201(10)
Methylglyoxal, Glyoxal, and Their Detoxification in Alzheimer' s Disease.
By BJÖRN KUHLA, HANS-JOACHIM LÜTH, DIETRICH HAFERBURG, KATHARINA BOECK, THOMAS ARENDT, AND GERALD MÜNCH
211(6)
Evaluation of Glyoxal and Methylglyoxal Levels in Uremic Patients under Peritoneal Dialysis.
By A. LAPOLLA, R. FLAMINI, A. LUPO, N.C. ARICÓ, C. RUGIU, R. REITANO, M. TUBARO, E. RAGAZZI, R. SERAGLIA, AND P. TRALDI
217(8)
Part III. Analytical Methods for Measuring Maillard Reaction Products
Application of Semiquantitative Proteomics Techniques to the Maillard Reaction.
By JENNIFER M. AMES
225(11)
The Carbon Module Labeling (CAMOLA) Technique: A Useful Tool for Identifying Transient Intermediates in the Formation of Maillard-Type Target Molecules.
By PETER SCHIEBERLE
236(13)
Analysis of Protein Glycation Products by MALDI-TOF/MS.
By THOMAS KISLINGER, ANDREAS HUMENY, CARLO C. PEICH, CORD-MICHAEL BECKER, AND MONIKA PISCHETSRIEDER
249(11)
Peptide Mapping of Human Serum Albumin Modified Minimally by Methylglyoxal in Vitro and in Vivo.
By NAILA AHMED AND PAUL J. THORNALLEY
260(7)
Advanced Glycation End Products/Peptides: An in Vivo Investigation.
By A. LAPOLLA, D. FEDELE, R. REITANO, L. BONFANTE, G. PASTORI, R. SERAGLIA, M. TUBARO, AND P. TRALDI
267(9)
A Convenient Method for Preparation of High-Purity, Amadori-Glycated Phosphatidylethanolamine and Its Prooxidant Effect.
By TERUO MIYAZAWA, JEONG-HO OAK, AND KIYOTAKA NAKAGAWA
276(4)
Tandem Mass Spectrometry Analysis of Amadori-Glycated Phosphatidylethanolamine in Human Plasma.
By TERUO MIYAZAWA, JEONG-HO OAK, AND KIYOTAKA NAKAGAWA
280(4)
Proteomic Method for the Quantification of Methionine Sulfoxide.
By J.W.C BROCK, W.C. COTHAM, J.M. AMES, S.R. THORPE, AND J.W. BAYNES
284(6)
Simple Noninvasive Measurement of Skin Autofluorescence.
By ROBBERT MEERWALDT, THERA LINKS, REINDERT GRAAFF, SUZANNE R. THORPE, JOHN BAYNES, JASPER HARTOG, REINOLD GANS, AND ANDRIES SMIT
290(9)
Accumulation of Advanced Glycation End Products, Measured as Skin Auto-fluorescence, in Renal Disease.
By JASPER W.L. HARTOG, AIKO P.J. DE VRIES, HELEN L. LUTGERS, ROBBERT MEERWALDT, ROEL M. HUISMAN, WILLEM J. VAN SON, PAUL E. DE JONG, AND ANDRIES J. SMIT
299(9)
Evaluation of the Maillard Reaction in Infant Formulas by Means of Front-Face Fluorescence.
By I. BIRLOUEZ-ARAGON, N. LOCQUET, E. DE ST LOUVENT, D. JOUAN-RIMBAUD BOUVERESSE, AND P. STAHL
308(11)
Part IV. Lipids and Lipoproteins in Nutrition and Disease
Interplay between the Maillard Reaction and Lipid Peroxidation in Biochemical Systems.
By FRANCISCO J. HIDALGO AND ROSARIO ZAMORA
319(8)
Isolevuglandins, Oxidatively Truncated Phospholipids, and Atherosclerosis.
By ROBERT G. SALOMON
327(16)
Role of Glucoxidation and Lipid Oxidation in the Development of Atherosclerosis.
By ERWIN SCHLEICHER, CORA WEIGERT, HELMUT ROHRBACH, ANDREAS NERLICH, BEATRICE BACHMEIER, AND ULRICH H. FRIESS
343(12)
Is Atherosclerosis a Multifactorial Disease or Is It Induced by a Sequence of Lipid Peroxidation Reactions?
By GERHARD SPITELLER
355(12)
The Immunogenicity of Modified Lipoproteins.
By MARIA F. LOPES-VIRELLA, SUZANNE R. THORPE, M. BROOKS DERRICK, CHARLYNE CHASSEREAU, AND GABRIEL VIRELLA
367(12)
Glycation Does Not Alter LDL-Induced Secretion of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 from Human Aortic Endothelial Cells.
By RICHARD L. KLEIN, ANDREA J. SEMLER, JOHN W. BAYNES, SUZANNE R. THORPE, TIMOTHY J. LYONS, AND ALICIA J. JENKINS
379(11)
Effects of Modified Low-Density Lipoproteins on Human Retinal Pericyte Survival.
By WEIWEI SONG, JEREMY L. BARTH, KANGMO Lu, YONGXIN YU, YAN HUANG, CYNTHIA K. GITTINGER, W. SCOTT ARGRAVES, AND TIMOTHY J. LYONS
390(6)
Acrolein Modifies Apolipoprotein A-I in the Human Artery Wall.
By BAOHAI SHAO, KEVIN D. O'BRIEN, THOMAS O. MCDONALD, XIAOYUN FU, JOHN F. ORAM, KOJI UCHIDA, AND JAY W. HEINECKE
396(8)
Lipid-Derived Modifications of Plasma Proteins in Experimental and Human Diabetes.
By ANDRZEJ S. JANUSZEWSKI, ALICIA J. JENKINS, JOHN W. BAYNES, AND SUZANNE R. THORPE
404(9)
Angiogenic Potency of Amadori-Glycated Phosphatidylethanolamine.
By KIYOTAKA NAKAGAWA, JEONG-HO OAK, AND TERUO MIYAZAWA
413(4)
Covalent Binding of Acetone to Aminophospholipids in Vitro and in Vivo.
By ARNIS KUKSIS, AMIR RAVANDI, AND MICHAEL SCHNEIDER
417(23)
Part V. Oxidative Stress, Diet, and Aging
Protective Role of Antioxidative Food Factors in Oxidative Stress Caused by Hyperglycemia.
By TOSHIHIKO OSAWA AND YOJI KATO
440(12)
Advanced Glycation in Health and Disease: Role of the Modern Environment
By HELEN VLASSARA
452(9)
Diet-Derived Advanced Glycation End Products Are Major Contributors to the Body's AGE Pool and Induce Inflammation in Healthy Subjects.
By JAIME URIBARRI, WEIJING CAI, OANA SANDU, MELPOMENI PEPPA, TERESIA GOLDBERG, AND HELEN VLASSARA
461(6)
Are Food Advanced Glycation End Products Toxic in Biological Systems?
By N.V. CHUYEN, H. ARAI, T. NAKANISHI, AND N. UTSUNOMIYA
467(7)
Studies on Absorption and Elimination of Dietary Maillard Reaction Products
By ANKE FÖRSTER, YVONNE KÜHNE, AND THOMAS HENLE
474(8)
Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats.
By KATARINA SEBEKOVÁ, THOMAS HOFMANN, PETER BOOR, KATARINA SEBEKOVÁ, JR., OL'GA ULICNÁ, HELMUT F. ERBERSDOBLER, JOHN W. BAYNES, SUZANNE R. THORPE, AUGUST HEIDLAND, AND VERONIKA SOMOZA
482(10)
Dietary Bread Crust Advanced Glycation End Products Bind to the Receptor for AGEs in HEK-293 Kidney Cells but Are Rapidly Excreted after Oral Administration to Healthy and Subtotally Nephrectomized Rats.
By VERONIKA SOMOZA, MICHAEL LINDENMEIER, THOMAS HOFMANN, OLIVER FRANK, HELMUT F. ERBERSDOBLER, JOHN W. BAYNES, SUZANNE R. THORPE, AUGUST HEIDLAND, HOLGER ZILL, STEPHAN BEK, JOCHEN HUBETZ, THOMAS WEIGLE, SABINE SCHEIDLER, ANDREAS E. BUSCH, AND KATARINA ŠEBEKOVÁ
492(9)
Biological and Chemical Assessment of Antioxidant Activity of Sugar-Lysine Model Maillard Reaction Products.
By DAVID D. KITTS AND CHUN HU
501(12)
Prevention of Oxidative Stress by Adenoviral Overexpression of GlutathioneRelated Enzymes in Pancreatic Islets.
By R. PAUL ROBERTSON, YOSHITO TANAKA, HIROKI TAKAHASHI, PHUONG OANH T. TRAN, AND JAMIE S. HARMON
513(8)
A Common Pathway for Intracellular Reactive Oxygen Species Production by Glycoxidative and Nitroxidative Stress in Vascular Endothelial Cells and Smooth Muscle Cells.
By NAOYUKI TANIGUCHI, MOTOKO TAKAHASHI, HARUHIKO SAKIYAMA, YONG SEEK PARK, MICHIO ASAHI, YOSHIKO MISONOU, AND YASUHADE MIYAMOTO
521(8)
An in Vitro Approach to the Chronological Aging of Skin by Glycation of the Collagen: The Biological Effect of Glycation on the Reconstructed Skin Model.
By HERVÉ PAGEON AND DANIEL ASSELINEAU
529(4)
Cross-Linking of the Extracellular Matrix by the Maillard Reaction in Aging and Diabetes: An Update on a Puzzle Nearing Resolution.
By VINCENT M. MONNIER, GEORGIAN T. MUSTATA, KLAUS L. BIEMEL, OLIVER REIHL, MARCUS o. LEDERER, DAI ZHENYU, AND DAVID R. SELL
533(12)
Oxidative Stress and Neurodegeneration.
By PAULA I. MOREIRA, MARK A. SMITH, XIONGWEI ZHU, AKIHIKO NUNOMURA, RUDY J. CASTELLANI, AND GEORGE PERRY
545(8)
Part VI. Role of Advanced Glycation End Products in Diabetes
Receptor for Advanced Glycation End Products and Its Ligands: A Journey from the Complications of Diabetes to Its Pathogenesis.
By WILLIAM KIM, BARRY I. HUDSON, BERNHARD MOSER, JIANCHENG GUO, LING LING RONG, YAN LU, WU QU, EVANTHIA LALLA, SHULAMIT LERNER, YALI CHEN, SHIRLEY SHI DU YAN, VIVETTE D' AGATI, YOSHIFUMI NAKA, RAVICHANDRAN RAMASAMY, KEVAN HEROLD, SHI FANG YAN, AND ANN MARIE SCHMIDT
553(9)
Receptor for Advanced Glycation End Products Is a Promising Target of Diabetic Nephropathy.
By YASUHIKO YAMAMOTO, TOSHIO DOI, ICHIRO KATO, HARUMICHI SHINOHARA, SHIGERU SAKURAI, HIDETO YONEKURA, TAKUO WATANABE, KIHN MAR MYINT, AI HARASHIMA, MASAYOSHI TAKEUCHI, SHIN TAKASAWA, HIROSHI OKAMOTO, NORIYOSHI HASHIMOTO, MASAHIDE ASANO, AND HIROSHI YAMAMOTO
562(5)
Glycation Products as Markers and Predictors of the Progression of Diabetic Complications.
By VINCENT M. MONNIER, DAVID R. SELL, AND SAUL GENUTH
567(15)
The Maillard Reaction in Eye Diseases.
By ALAN W. STITT
582(16)
Role of Advanced Glycation End Products and Their Receptors in Development of Diabetic Neuropathy.
By RYUICHI WADA AND SOROKU YAGIHASHI
598(7)
Synergistic Contributions of Carbonyl Stress and Megsin in Diabetic Nephropathy.
By REIKO INAGI, MASAOMI NANGAKU, AND TOSHIO MIYATA
605(4)
Effects of Advanced Glycation End Products on Ezrin-Dependent Functions in LLC-PK1 Proximal Tubule Cells.
By LEON A. BACH, MARISA A. GALLICCHIO, E. ANNE MCROBERT, ANJALI TIKOO, AND MARK E. COOPER
609(8)
Localization of the Ezrin Binding Epitope for Glycated Proteins.
By E. ANNE MCROBERT, ANJALI TIKOO, MARISA A. GALLICCHIO, MARK E. COOPER, AND LEON A. BACH
617(8)
Processing Advanced Glycation End Product–Modified Albumin by the Renal Proximal Tubule and the Early Pathogenesis of Diabetic Nephropathy.
By AYLIN M. OZDEMIR, ULRICH HOPFER, PENNY ERHARD, VINCENT M. MONNIER, AND MIRIAM F. WEISS
625(12)
Significance of Proximal Tubular Metabolism of Advanced Glycation End Products in Kidney Diseases.
By AKIHIKO SAITO, TETSURO TAKEDA, KIYOKO SATO, HITOMI HAMA, ATSUHITO TANUMA, RYOHEI KASEDA, YOSHIKI SUZUKI, AND FUMITAKE GEJYO
637(7)
Low–Molecular Weight Advanced Glycation End Products: Markers of Tissue AGE Accumulation and More?
By MERLIN C. THOMAS, JOSEPHINE M. FORBES, RICHARD MACISAAC, GEORGE JERUMS, AND MARK E. COOPER
644(11)
Plasma Low–Molecular Weight Fluorescence in Type 1 Diabetes Mellitus.
By A.S. JANUSZEWSKI, M.C. THOMAS, S.J. CHUNG, C.S. KARSCHIMKUS, K.G. ROWLEY, C. NELSON, D. O'NEAL, Z. WANG, J.D. BEST, AND A.J. JENKINS
655(7)
Plasma Levels of AGE Peptides in Type 1 Diabetic Patients Are Associated with Serum Creatinine and Not with Albumin Excretion Rate: Possible Role of AGE Peptide-Associated Endothelial Dysfunction.
By CASPER G. SCHALKWIJK, PIET M. TER WEE, AND COEN D.A. STEHOUWER
662(9)
Part VII. Role of Advanced Glycation End Products in Organ Dysfunction and Disease
Pathological Roles of Advanced Glycation End Product Receptors SR-A and CD36.
By SEIKOH HORIUCHI, YUKA UNNO, HITOMI USUI, KENICHI SHIKATA, KAORI TAKAKI, WAKAKO KOITO, YU-ICHIRO SAKAMOTO, RYOJI NAGAI, KENJI MAKINO, AKIRA SASAO, JUN WADA, AND HIROFUMI MAKINO
671(5)
Advanced Glycation End Product Receptor–Mediated Cellular Dysfunction.
By ANGELIKA BIERHAUS, PER M. HUMPERT, DAVID M. STERN, BERND ARNOLD, AND PETER P. NAWROTH
676(5)
Advanced Glycation End Products: A Possible Link to Angiotensin in an Animal Model.
By JÜRGEN BOHLENDER, SYBILLE FRANKE, MANFRED SOMMER, AND GÜNTER STEIN
681(4)
Genotoxicity of Advanced Glycation End Products: Involvement of Oxidative Stress and of Angiotensin II Type 1 Receptors.
By NICOLE SCHUPP, REINHARD SCHINZEL, AUGUST HEIDLAND, AND HELGA STOPPER
685(11)
Glycoaldehyde-Modified Bovine Serum Albumin Downregulates Leptin Expression in Mouse Adipocytes via a CD36-Mediated Pathway.
By YUKA UNNO, MASAKAZU SAKAI, YU-ICHIRO SAKAMOTO, AKIHIKO KUNIYASU, RYOJI NAGAI, HITOSHI NAKAYAMA, AND SEIKOH HORIUCHI
696(6)
Aldose Reductase and AGE-RAGE Pathways: Key Players in Myocardial Ischemic Injury.
By MICHIYO KANEKO, LOREDANA BUCCIARELLI, YUYING C. HWANG, LARISEE LEE, SHI FANG YAN, ANN MARIE SCHMIDT, AND RAVICHANDRAN RAMASAMY
702(8)
Advanced Glycation End Products and Bone Loss during Aging.
By PATRIZIO ODETTI, SIMONA ROSSI, FIAMMETTA MONACELLI, ALESSIA POGGI, MARIA CIRNIGLIARO, MARCELLO FEDERICI, AND ALBERTO FEDERICI
710(8)
Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It.
By NAILA AHMED, REINHARD LÜTHEN, DIETER HÄUSSINGER, KATARINA ŠEBEKOVÁ, REINHARD SCHINZEL, WOLFRAM VOELKER, AUGUST HEIDLAND, AND PAUL J. THORNALLEY
718(7)
Advanced Glycation End Products in Human Cancer Tissues: Detection of Nepsilon-(Carboxymethyplysine and Argpyrimidine.
By JEROEN W.J. VAN HEIJST, HANS W.M. NIESSEN, KLAAS HOEKMAN, AND CASPER G. SCHALKWIJK
725(9)
Advanced Glycation End Product Free Adducts Are Cleared by Dialysis.
By S. AGALOU, N. AHMED, P.J. THORNALLEY, AND A. DAWNAY
734(6)
Part VIII. Inhibitors of the Maillard Reaction
From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy.
By TOSHIO MIYATA, MAKOTO YAMAMOTO, AND YUKO IZUHARA
740(10)
Can Advanced Glycation End Product Inhibitors Modulate More than One Pathway to Enhance Renoprotection in Diabetes?
By MELINDA T. COUGHLAN, MARK E. COOPER, AND JOSEPHINE M. FORBES
750(9)
Advanced Glycation End Products in Diabetes-Associated Atherosclerosis and Renal Disease: Interventional Studies.
By KARIN A. JANDELEIT-DAHM, MARKUS LASSILA, AND TERRI J. ALLEN
759(8)
Renoprotective and Lipid-Lowering Effects of LR Compounds, Novel Advanced Glycation End Product Inhibitors, in Streptozotocin-Induced Diabetic Rats.
By JAMES LESTER FIGAROLA, STEVEN SCOTT, SOFIA LOERA, BIXIN XI, TIMOTHY SYNOLD, AND SAMUEL RAHBAR
767(10)
High-Dose Thiamine Therapy Counters Dyslipidemia and Advanced Glycation of Plasma Protein in Streptozotocin-Induced Diabetic Rats.
By NIKOLAOS KARACHALIAS, ROYA BABAEI-JADIDI, CHRISTIAN KUPICH, NAILA AHMED, AND PAUL J. THORNALLEY
777(7)
Inhibitors of Advanced Glycation End Product Formation and Neurovascular Dysfunction in Experimental Diabetes.
By NORMAN E. CAMERON, T. MICHAEL GIBSON, MATTHEW R. NANGLE, AND MARY A. COTTER
784(9)
Post-Amadori AGE Inhibition as a Therapeutic Target for Diabetic Complications: A Rational Approach to Second-Generation Amadorin Design.
By RAJA G. KHALIFAH, YING CHEN, AND JAMES J. WASSENBERG
793(14)
Pyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor.
By PAUL A. VOZIYAN AND BILLY G. HUDSON
807(10)
Tissue-Specific Variation in Glycation of Proteins in Diabetes: Evidence for a Functional Role of Amadoriase Enzymes.
By SARAH M. BROWN, DELLA M. SMITH, NADJA ALT, SUZANNE R. THORPE, AND JOHN W. BAYNES
817(7)
Some Clues as to the Regulation, Expression, Function, and Distribution of Fructosamine-3-Kinase and Fructosamine-3-Kinase–Related Protein.
By JAMES R. CONNER, PAUL J. BEISSWENGER, AND BENJAMIN S. SZWERGOLD
824(13)
Substrate Specificity of Amadoriase I from Aspergillus fumigatus.
By CARMELA MENNELLA, ROSA CINZIA BORRELLI, FRANCESCO VINALE, MICHELINA RUOCCO, AND VINCENZO FOGLIANO
837(8)
Transglycation—A Potential New Mechanism for Deglycation of Schiff's Bases.
By BENJAMIN S. SZWERGOLD, SCOTT K. HOWELL, AND PAUL J. BEISSWENGER
845(20)
Proteins of Thermus thermophilus Are Resistant to Glycation-Induced Protein Precipitation: An Evolutionary Adaptation to Life at Extreme Temperatures?
By GERALD MÜNCH, KATRIN BERBAUM, CHRISTIN URBAN, AND REINHARD SCHINZEL
865(11)
Mail lard Reaction Products Derived from Thiol Compounds as Inhibitors of Enzymatic Browning of Fruits and Vegetables: The Structure-Activity Relationship.
By C. BILLAUD, C. MARASCHIN, M.-N. PEYRAT-MAILLARD, AND J. NICOLAS
876(10)
Part IX. Poster Abstracts
The Life and Works of L.C. Maillard: Some Interesting Aspects of His Biography.
By PAUL A. FINOT AND J. ADRIAN
886(1)
Pronyl-Lysine—A Novel Protein Modification in Bread Crust Melanoidins Showing in Vitro Antioxidative and Phase I/II Enzyme Modulating Activity.
By T. HOFMANN, M. LINDENMEIER, AND V. SOMOZA
887(1)
Can Histidines Stabilize a Carnosine-Derived Pyrazinium Radical?
By N.W. SEIDLER AND G.S. YEARGANS
888(1)
The Interaction of Heavy Metals (Cu, Fe, and Zn) with Maillard Reaction Products in the Lactose-Glycine System.
By D.T. RAMONAITYTE, M. KERSIENE, AND B. MOCKAITIENE
889(1)
Modeling the Maillard Reaction: Schiff Base Formation.
By LAI PENG LEONG AND RYAN P.A. BETTENS
890(1)
Creating Caseinate Glycoconjugates with Novel Functionality through the Maillard Reaction.
By C. OLIVER, L. MELTON, AND R. STANLEY
891(1)
A Rapid Fluorimetric Method to Predict the Browning and HMF Content of Biscuits.
By L. AIT AMEUR, C. CHIPEAUX, M. ZUDE, G. TRYSTRAM, AND I. BIRLOUEZ-ARAGON
892(1)
Influence of High Hydrostatic Pressure on the Formation of Maillard-Derived Key Odorants and Chromophores.
By T. HOFMANN, F. DETERS, I. HEBERLE, AND P. SCHIEBERLE
893(1)
The Effect of Water Content on Volatile Formation from the Maillard Reaction of Peptides and Glucose.
By C.Y. LU, R. PAYNE, AND C.T. HO
894(1)
The Roles of Free and Bound Amino Acids in Maillard Aroma Generation.
By C.T. HO, C.Y. LU, C.P. LIANG, AND M. WANG
895(1)
Volatile Components in Pork Semimembranosus Panfried at Two Pan Temperatures.
By M.D. AASLYNG, A. SCHÄFER, L. LAURIDSEN, AND L. ANDERSEN
896(1)
Degradation of Amadori Compounds by Flavin Adenine Dinucleotide.
By H.A. WATANABE, T.A. NAGATAKE, M.A. NAIKI, M.A. HASHIMOTO, K.A. ITO, AND F.B. HAYASE
897(1)
Neurotoxic Tetrahydroisoquinoline Derivatives Formed by the Maillard Reaction between Glucose and Dopamine.
By KYOZO SUYAMA, YOSHIHISA ISHII, AND MITSUGU AKAGAWA
898(1)
Isolation and Identification of Glyceraldehyde-Derived Advanced Glycation End Products.
By T. USUI, K. SHIMOHIRA, H. WATANABE, AND F. HAYASE
899(1)
Antioxidant Properties of Proline-Glucose-Ferulic Acid Model Malt Systems
By THOMAS S. SAMARAS, MICHEL M. GORDON, AND JENNIFER M. AMES
900(1)
The Effect of Oxidation on the Antioxidant Activity of Phospholipids.
By F.J. HIDALGO, F. NOGALES, AND R. ZAMORA
901(1)
PA49.5, the Principal Asset of Lactococcus lactis Sp. cremoris ATCC 9596
By E. DAKO, A. ASSELIN, AND E.R. SIMARD
902(1)
Specific MS/MS Fragmentation of Lysine, Arginine, and Ornithine Glycation Products Provides an Opportunity for Their Selective Detection in Protein Acid Hydrolysates and Enzymatic Digests.
By O.K. ARGIROV, N.D. LEIGH, AND B.J. ORTWERTH
903(1)
Site Specificity of Glycation and Nepsilon-(Carboxymethyl)Lysine Formation on Bovine Serum Albumin Modified by Glucose and Fructose.
By D.J.S. HINTON AND J.M. AMES
904(1)
Peptide Mapping of Human Hemoglobin Modified Minimally by Methylglyoxal in Vitro.
By Y. CHEN, N. AHMED, AND P.J. THORNALLEY
905(1)
Peptide Mapping of Type IV Collagen Modified Minimally by Methylglyoxal in Vitro.
BY DARIN DOBLER, NAILA AHMED, AND PAUL J. THORNALLEY
906(1)
Protein Glycation and Oxidation in Cola and Pasteurized Milk.
By L. KENNISH, D. DOBLER, N. AHMED, AND P.J. THORNALLEY
907(1)
Biological Response of Advanced Glycation End Products to the Established Cell Line and Proteome Analysis.
By S. OMURA, A. TAYA, S. MASUDA, H. NAITOU, N. OHASHI, AND N. KINAE
908(1)
Proteomic Analysis of the Secreted Proteins of the B3 Line of Transformed Human Lens Epithelial (HLE-B3) Cells That Were Exposed to the Cytotoxicity of the Oxidation-Derived Aldehyde.
By HIROKO ODANI, TOYOFUMI NAKANISHI, AND VINCENT M. MONNIER
909(1)
Quantification of Advanced Glycation End Product and Oxidative Stress Biomarkers in Human Urine.
By YOJI KATO, NOBUHIKO MIZUKAWA, JUN-ICHI YANO, TOMOYOSHI HOSOKAWA, AKIHIRO YOSHIDA, MICHITAKA NAITO, YOSHICHIKA KAWAI, KENTARO TSUJI, NORITOSHI KITAMOTO, MASAYASU KITAMURA, AND TOSHIHIKO OSAWA
910(1)
Skin Autofluorescence, a Noninvasive Measure of Advanced Glycation End Product Accumulation, Is a Predictor of Mortality in Hemodialysis Patients.
By R. MEERWALDT, R. GRAAFF, T.P. LINKS, J.W. BAYNES, G.J. NAVIS, R.M. HUISMAN, R.O.B. GANS, AND A.J. SMIT
911(1)
Short-Term Sugar Exposure Significantly Modifies FGF-2 Structure and Angiogenic Functions: Pathophysiological Implications.
By F. FACCHIANO, A. FACCHIANO, K. RUSSO, C. MENNELLA, R. RAGONE, D. RIBATTI, M.C. CAPOGROSSI, AND V. FOGLIANO
912(1)
Advanced Glycation End Product–Modified Protein and αβ-Dicarbonyls Affect Cisplatin Concentration in Blood.
By KAZUHIRO YOSHIHARA, YOSHIAKI NAGAYAMA, KENTARO SAITO, HIDEAKI HORIGUCHI, SATORU TAKAHASHI, NOBUHIKO SAITO, SHIN-ICHIRO YOSHIDA, AND MASATOSHI BEPPU
913(1)
Protein Glycation Marker Residues and Free Adducts of Cerebrospinal Fluid in Alzheimer's Disease and a Link to Cognitive Impairment.
By N. AHMED, U. AHMED, K. HAGER, G. FLEISCHER, G. MÜNCH, AND P.J. THORNALLEY
914(1)
Involvement of the Metabolic Syndrome and Renal Injury by Low-Calorie Diet Is Associated with Renal AGE Reduction in Rat Type 2 Diabetic Nephropathy.
By M. NANGAKU, R. INAGI, N. ISHIKAWA, Y. IZUHARA, AND T. MIYATA
915(1)
Overexpression of GLUT4 in Muscle and Heart Leads to Increased Cardiac Myosin Glycation and Early Death: Suppression by Caloric Restriction.
By VINCENT M. MONNIER, CHRISTOPHER STRAUCH, ASHWINI VISWANATHAN, DAVID R. SELL, AND ROGER J. MCCARTER
916(1)
Skin Collagen–Linked Fluorescence Predicts Atherosclerosis Progression in the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
By V.M. MONNIER, O. BAUTISTA, P. CLEARY, D.R. SELL, S. GENUTH, AND THE DCCT/EDIC RESEARCH GROUP
917(1)
Exogenous Methylglyoxal Induces Diabetes-like Microvascular Changes in Rats.
By J. BERLANGA, D. CIBRIAN, I. GUILLÉN, F. FREYRE, J.S. ALBA, N. MERINO, A. ALDAMA, A.M. QUINTELA, M.E. TRIANA, H. AJAMEICH, P. LOPEZ, N. AHMED, AND P.J. THORNALLEY
918(1)
Association of the Cluster of Genetic Risk Factors in Loci Related to Glycoxidation with Diabetic Nephropathy in Type 2 Diabetes Mellitus.
By K. KANKOVÁ, A. STEJSKALOVÁ, L. PÁCAL, M. HERTLOVÁ, AND D. KRUSOVÁ
919(1)
Advanced Glycation End Products and Chemokines in the Serum and Urine of Patients with Chronic Allograft Nephropathy and IgA-NephropathyRelation to Chronic Damage and Inflammation.
By M. RUESTER, S. FRANKE, AND G. STEIN
920(1)
Advanced Glycation End Product Excretion Rates by Peritoneal Dialysis in End-Stage Renal Disease.
By S. AGALOU, N. AHMED, A. DAWNAY, AND P.J. THORNALLEY
921(1)
Removal of Free Advanced Glycation End Products by Hemodialysis.
By S. AGALOU, N. AHMED, P.J. THORNALLEY, AND A. DAWNAY
922(1)
Effects of Vitamin E Alpha on Thrombotic Events and Markers of Oxidation and Inflammation in Hemodialysis.
By M.F. WEISS, W.D. SCHWING, C. HOLLOMAN, C. SIEGEL, J. VALENTE, P. DEOREO, P. ERHARD, AND V.M. MONNIER
923(1)
Ultrapure Dialysate Decreases Plasma Pentosidine, a Marker of Carbonyl Stress, in Hemodialysis Patients.
By YUKO IZUHARA, NAOYOSHI ISHIKAWA, REIKO INAGI, AND TOSHIO MIYATA
924(1)
Reduced Circulating AGE Levels and Lower Genomic Damage in Patients Undergoing Daily versus Standard Hemodialysis.
By EVANGELIA FRAGEDAKI, MICHAEL NEBEL, NICOLE SCHUPP, KATARINA ŠEBEKOVÁ, WOLFGANG VÖLKEL, ANDRÉ KLASSEN, MONIKA PISCHETSRIEDER, MATTHIAS FRISCHMANN, TOSHIMITSU NIWA, JÖRG VIENKEN, AUGUST HEIDLAND, AND HELGA STOPPER
925(1)
Advanced Glycation End Product–Induced DNA Damage: Involvement of Angiotensin II.
By N. SCHUPP, U. LAKNER, K. ŠEBEKOVÁ, A. HEIDLAND, AND H. STOPPER
926(1)
Interactions between the Renin Angiotensin System and Advanced Glycation in Diabetic Nephropathy.
By M.C. THOMAS, J.M. FORBES, AND M.E. COOPER
927(1)
Increased Plasma and Urinary Methylglyoxal-Derived Hydroimidazolone in Type 1 Diabetic Patients.
By N. AHMED, R. BABAEI-JADIDI, P.J. THORNALLEY, S.K. HOWELL, AND P.J. BEISSWENGER
928(1)
Heavily Oxidized-Glycated LDL Inhibits Tissue Inhibitor of Metalloproteinase-3 Expression in Human Retinal Capillary Pericytes.
By WEIWEI SONG, KANGMO LU, YAN HUANG, JEREMY BARTH, SCOTT ARGRAVES, AND TIMOTHY LYONS
929(1)
Platelet Adhesion to Glycated GFOGER Peptide and Bovine Serum Albumin
By D.A. SLATTER AND R.W. FARNDALE
930(1)
Characterization of a Glycoaldehyde-Modified Model of the Diabetic Basement Membrane: Relevance to Pathological Responses during Diabetes.
By NORMA FRIZZELL, ALAN W. STITT, AND SUZANNE R. THORPE
931(1)
Effect of Glucose Concentration on the Formation of Advanced Glycation End Products in Erythrocytes in Vitro.
By E.K. DEEMER, R. NAGAI, J.W.C. BROCK, S.R. THORPE, AND J.W. BAYNES
932(1)
The Internalization of 3-Deoxyglucosone in Human Umbilical Vein Endothelial Cells.
By H. SAKIYAMA, M. TAKAHASHI, T. YAMAMOTO, T. TESHIMA, AND N. TANIGUCHI
933(1)
The Effects of Advanced Glycation End Products (AGEs) on Endothelial Cell Nitric Oxide Synthase and Tumor Necrosis Factor-α Expression Are AGE Receptor Dependent.
By G. RASHID, S. BENCHETRIT, D. FISHMAN, AND J. BERNHEIM
934(1)
Identification of N-Methylpyridinium as a Key Chemopreventive Compound and a RAGE Ligand in Coffee Beverage Using in Vitro and in Vivo Techniques.
By V. SOMOZA, M. LINDENMEIER, E. WENZEL, O. FRANK, S. BEK, J. HUBER, B. WEIGLE, S. SCHEIDLER, A.E. BUSCH, H.F. ERBERSDOBLER, AND T. HOFMANN
935(1)
Prevention of Diabetic Ocular Complications in Spontaneously Diabetic Torii Rats by the Aldose Reductase Inhibitor Fidarestat.
By A. KAKEHASHI, Y. SAITO, K. MORI, R. ONO, N. SUGI, H. YAMAGAMI, M. KUROKI, H. TAMEMOTO, S. ISHIKAWA, M. KAWAKAMI, Y. KANAZAWA, H. HIROOKA, AND N. KATO
936(1)
Prevention of Diabetic Ocular Complications in Spontaneously Diabetic Torii Rats by Aminoguanidine.
By A. KAKEHASHI, Y. SAITO, K. MORI, R. ONO, N. SUGI, H. YAMAGAMI, M. KUROKI, H. TAMEMOTO, S. ISHIKAWA, M. KAWAKAMI, AND Y. KANAZAWA
937(1)
Carotenoids as Antioxidants for the Prevention of Diabetic Complications.
By K. TOMISAKA AND N.V. CHUYEN
938(1)
Evidence for Variations in Deglycating Activity among Tissues in the Diabetic Rat.
By S.M. BROWN, D.M. SMITH, S.R. THORPE, AND J.W. BAYNES
939(1)
Green Tea (Camellia sinensis) Ameliorates Retinopathy and Renal Mitochondrial Defects but Deteriorates Collagen Glycoxidation and Cross-Linking in Experimental Diabetes.
By GEORGIAN T. MUSTATA, MARIANA G. ROSCA, OLIVER REIHL, KLAUS BIEMEL, MARK A. SMITH, ASHWINI VISHWANATHAN, CHRISTOPHER STRAUCH, YUN PENG DU, TIMOTHY S. KERN, MARKUS LEDERER, MICHAEL BROWNLEE, MIRIAM F. WEISS, AND VINCENT M. MONNIER
940(1)
Aspirin Inhibits Pentosidine Formation in Collagen Incubated with Glucose.
By P. URIOS, A.M. BORSOS, C. GIRARD, AND M. STERNBERG
941(1)
Effects on Glycation of Valsartan Therapy in Vivo.
By P. ODETTI, A. POGGI, F. MONACELLI, S. ROSSI, A. DURANTE, M. CIRNIGLIARO, L. RICCA, AND G.L. VIVIANI
942(1)
In Vitro and in Vivo Evidence for the AGE-Inhibitory Property of Antihypertensive Agents.
By YUKO IZUHARA, NAOYOSHI ISHIKAWA, REIKO INAGI, MASAOMI NANGAKU, AND TOSHIO MIYATA
943(1)
Quantification of Advanced Glycation End Products in Diabetic Animal Tissues by RP-HPLC: An Investigation of the Role of Pyridoxamine.
By NORMA FRIZZELL, ALAN W. STITT, AND SUZANNE R. THORPE
944(1)
Amadori-Lysyl–Induced Propagation of Protein Modifications Is Inhibited by Pyridoxamine.
By P.A. VOZIYAN, S.V. CHETYRKIN, AND B.G. HUDSON
945(1)
Cleavage of Dicarbonyl Compounds by the Advanced Glycation/Lipoxidation End Product Inhibitor Pyridoxamine.
By M.L. STROMAN, T.O. METZ, S.R. THORPE, AND J.W. BAYNES
946(1)
High Glucose and Advanced Glycation End Products Inhibit the Proliferation of Cultured Endothelial Cells: Protection by Vitamin E.
By J. ZHANG, M. SLEVIN, Y. DURAISAMY, C.A. SMITH, J. GAFFNEY, AND N. AHMED
947(2)
Index of Contributors 949

Rewards Program

Reviews for The Maillard Reaction: Chemistry at the Interface of Nutrition, Aging, and Disease, Annals of the New York Academy of Sciences, Volume 1043 (9781573315326)